About the Authors
- Frederic Ries
-
Roles Methodology, Writing – original draft
Affiliation Department of Hematology and Medical Oncology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany,
- Matthias Klein
-
Roles Methodology, Resources
Affiliations Institute for Immunology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany, Research Center for Immunotherapy (FZI), Mainz, Germany
- Nora Rogmann
-
Roles Methodology
Affiliation Department of Hematology and Medical Oncology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany,
- Sophie Többen
-
Roles Methodology
Affiliation Department of Hematology and Medical Oncology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany,
- Federico Marini
-
Roles Methodology
Affiliations Research Center for Immunotherapy (FZI), Mainz, Germany, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg-University, Mainz, Germany
- Florian Heidel
-
Roles Conceptualization, Methodology
Affiliations Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Germany, Leibniz-Institute on Aging, Fritz-Lipmann-Institute, Jena, Germany
- Markus P. Radsak
-
Roles Conceptualization, Data curation, Funding acquisition, Investigation, Writing – original draft, Writing – review & editing
* E-mail: radsak@uni-mainz.de
Current address: Department of Oncology and Hematology, Donau-Isar-Klinikum, Deggendorf, Germany
Affiliations Department of Hematology and Medical Oncology, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany,, Research Center for Immunotherapy (FZI), Mainz, Germany
Competing Interests
F.R., S.T., M.K., F.M., M.R., and N.R. declare that they have no conflicts of interest related to the studies. FHH served as an advisor for Novartis, CTI, Celgene/BMS, Janssen, Abbvie, GSK, Merck and AOP and received research funding from Novartis, Celgene/BMS and CTI.